Skip to content

Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery

Power Lung Versus Acapella on Airway Clearance After Coronary Artery Bypass Graft Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05260944
Enrollment
90
Registered
2022-03-02
Start date
2021-08-05
Completion date
2023-08-05
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Surgery

Brief summary

The purpose of the study is to compare between the power lung versus acapella on airway clearance after coronary artery bypass graft surgery.

Detailed description

In this part of the study the materials and methods will be presented under the following headings: subjects, equipments, procedures of the study and statistical procedures 1. Subjects. Ninty patients of both sexes will participate in this study with an age range of 40 to 50 years old. They will be chosen from outpatient clinic, Qena University Hospital. Patients will be randomely assigned into three groups: Group A: patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration. Group B: patients will receive a two supervised session using power lung device three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration). Group C. Patients will receive only routine physical Therapy program. 2. Equipment: 1\. For evaluation: Arterial blood gases including: - paO2, paCO2, PH and O2 saturation. Spirometry measurements: - as forced vital capacity (FVC) andbforced expiratory volume in the first second (FEV1). The incidence of PPCs and the length of postoperative stay: - using the Melbourne Group Scale Dyspnea. According to the revised or modified Borg scale or rating of perceived exersion. The Rand SF 36 health survey questionnaire. 2. For treatment The power lung device. Acapella device.

Interventions

patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

DEVICEPower lung device

Group B. patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

Group C. Thirty patients will receive only routine physical Therapy program

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

The participants are the patients who undergoing coronary artery bypass graft surgery. The care providers are the cardiothoraci surgeon and the nursing staff. The investigator is the physical Therapy ( my self)

Intervention model description

In the study three groups of patients will participated first, group A. Will receive acapella device. Second, group B. Will receive power lung device. Third, group C. Will receive only routine physical Therapy program.

Eligibility

Sex/Gender
ALL
Age
40 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* They will be from 40-50 years old. * They will be patients undergo elective CABG surgery. * Non productive cough postoperatively. * Cough pain intensity \> 5 as rated on a visual analogue scale (VAS) on postoperative day 1.

Exclusion criteria

* Patients with chronic chest diseases. * Patients with an intensive postoperative care (ICU) stay \> 48 hrs. * Uncooperative patients.

Design outcomes

Primary

MeasureTime frameDescription
Arterial blood gases including:One weekPartial pressure of oxygen (paO2), partial pressure of carbon dioxide (paCO2), power of hydrogen (PH)and O2 saturation.

Secondary

MeasureTime frameDescription
SpirometryOne weekAs forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and the FEV1/FVC.

Other

MeasureTime frameDescription
DyspneaOne weekAccording to revised or modified Borg or rating of perceived exertion.
The incidence of postoperative pulmonary complicationsOne weekAccording to Melbourne group scale.
Quality of lifeOne weekAccording to the Rand SF 36 health survey questionnaire.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026